Topiramate and Valproate Compared in Treatment of Juvenile Myoclonic Epilepsy

Abstract

A pilot, randomized, controlled trial comparing topiramate (n=19) and valproate (n=9) in adolescents/adults with juvenile myoclonic epilepsy (JME) was conducted in the Childrens Hospitals of Denver, CO, and Cincinnati, OH.

Keywords

• juvenile myoclonic epilepsy
• systemic toxicity
• valproate